<?xml version="1.0" ?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" 
 xmlns:mml="http://www.w3.org/1998/Math/MathML">
	<teiHeader>
		<fileDesc xml:id="f_45"/>
	</teiHeader>
	<text>
		<front/>
		<body/>
		<back>
			<listBibl>
<biblStruct coords="10,69.36,123.96,463.56,12.22" >
	<analytic>
		<title/>
		<author>
			<persName>
				<forename type="first">.......................................................................</forename>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Box 1. Drug safety monitoring and consumer protection</title>
		<imprint>
			<biblScope unit="page">12</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="10,69.36,136.56,465.38,12.22;10,69.36,149.28,463.55,12.22" >
	<monogr>
		<title level="m" type="main">Drug coverage in selected provinces and in the federal Non-insured Health Benefits programme20 Box 3. Formulary listing processes used in selected drug coverage schemes</title>
		<author>
			<persName>
				<forename type="first">.........................................</forename>
			</persName>
		</author>
		<imprint>
			<biblScope unit="page">23</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="10,69.36,161.88,463.56,12.22" >
	<monogr>
		<title level="m" type="main">Evidence of the impact of formulary listing on consumption patterns</title>
		<author>
			<persName>
				<forename type="first">........................................</forename>
				<surname>Box 4</surname>
			</persName>
		</author>
		<imprint>
			<biblScope unit="page">27</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="10,69.36,174.60,463.54,12.22" >
	<monogr>
		<title level="m" type="main">Cost-sharing arrangements in selected provincial drug plans</title>
		<author>
			<persName>
				<forename type="first">.....................................................</forename>
			</persName>
		</author>
		<imprint>
			<biblScope unit="page">33</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="10,69.36,187.20,463.56,12.22" >
	<monogr>
		<title level="m" type="main">Canadian evidence on the impact of cost-sharing on drug use</title>
		<author>
			<persName>
				<forename type="first">....................................................</forename>
			</persName>
		</author>
		<imprint>
			<biblScope unit="page">34</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="10,69.36,199.92,463.52,12.22" >
	<analytic>
		<title/>
		<author>
			<persName>
				<forename type="first">Canada...........................................</forename>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Box 7. Developing a new national strategy for pharmaceuticals</title>
		<imprint>
			<biblScope unit="page">37</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="10,69.36,212.52,463.56,12.22" >
	<monogr>
		<title/>
		<author>
			<persName>
				<surname>Box 8</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">.......................................................................................................................</forename>
				<surname>Cross-Border Trade</surname>
			</persName>
		</author>
		<imprint>
			<biblScope unit="page">55</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="10,69.36,225.12,463.56,12.22;81,259.20,172.20,73.98,12.22" >
	<analytic>
		<title/>
		<author>
			<persName>
				<forename type="first">..............................................................................</forename>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Box 9. Methods used in PMPRB price comparisons</title>
		<imprint>
			<biblScope unit="page">73</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="81,59.52,220.56,471.27,12.22;81,87.84,233.28,384.94,12.22" >
	<analytic>
		<title level="a" type="main">Demystifying medication safety: Making sense of terminology</title>
		<author>
			<persName>
				<forename type="first">S</forename>
				<surname>Ackroyd-Stolarz</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">N</forename>
				<surname>Hartnell</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">N</forename>
				<forename type="middle">J</forename>
				<surname>Mackinnon</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Research in Social and Administrative Pharmacy</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="280" to="289" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="81,59.52,257.88,426.82,12.22;81,87.84,270.60,137.04,12.22" >
	<analytic>
		<title level="a" type="main">Price regulation of pharmaceuticals in Canada</title>
		<author>
			<persName>
				<forename type="first">A</forename>
				<surname>Anis</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">Q</forename>
				<surname>Wen</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Health Economics</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="21" to="38" />
			<date type="published" when="1998" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="81,59.52,295.20,472.11,12.22;81,87.84,307.92,234.00,12.22" >
	<analytic>
		<title level="a" type="main">A Dog&apos;s Breakfast: Prescription drug coverage varies widely across Canada</title>
		<author>
			<persName>
				<forename type="first">A</forename>
				<surname>Anis</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">D</forename>
				<surname>Guh</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">X</forename>
				<forename type="middle">H</forename>
				<surname>Wang</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Medical Care</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="315" to="326" />
			<date type="published" when="2001" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="81,59.52,332.52,470.25,12.22;81,87.84,345.12,413.48,12.22;81,87.84,357.84,392.28,12.22" >
	<analytic>
		<title level="a" type="main">When patients have to pay a share of drug costs: effects on frequency of physician visits, hospital admissions and filling of prescriptions</title>
		<author>
			<persName>
				<forename type="first">A</forename>
				<surname>Anis</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">D</forename>
				<surname>Guh</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">D</forename>
				<surname>Lacaille</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">C</forename>
				<surname>Marra</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">A</forename>
				<surname>Rashidi</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">X</forename>
				<surname>Li</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">J</forename>
				<surname>Esdaile</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Canadian Medical Association Journal</title>
		<imprint>
			<biblScope unit="volume">173</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1335" to="1340" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="81,59.52,382.44,453.82,12.22;81,87.84,395.16,420.19,12.22" >
	<monogr>
		<title level="m" type="main">Canadians&apos; access to insurance for prescription medicines, Volumes 1: Range and extent of coverage</title>
		<author>
			<persName>
				<forename type="first">Applied</forename>
				<surname>Management</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">Fraser</forename>
				<surname>Group</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">Tristat</forename>
				<surname>Resources</surname>
			</persName>
		</author>
		<imprint>
			<date type="published" when="2000" />
		</imprint>
	</monogr>
	<note>submitted. to Health Canada</note>
</biblStruct>

<biblStruct coords="81,59.52,419.76,451.05,12.22;81,87.84,432.36,440.66,12.22" >
	<monogr>
		<title level="m" type="main">Canadians&apos; access to insurance for prescription medicines, Volumes 2: The un-insured and under-insured, submitted to Health Canada</title>
		<author>
			<persName>
				<forename type="first">Applied</forename>
				<surname>Management</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">Fraser</forename>
				<surname>Group</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">Tristat</forename>
				<surname>Resources</surname>
			</persName>
		</author>
		<imprint>
			<date type="published" when="2000" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="81,59.52,457.08,438.40,12.22;81,87.84,469.68,435.12,12.22;81,87.84,482.40,281.86,12.22" >
	<monogr>
		<title level="m" type="main">How Common are the Provincial/ Territorial Public Drug Formularies?, Poster Exhibition at Toward a National Pharmaceuticals Strategy</title>
		<author>
			<persName>
				<forename type="first">M</forename>
				<surname>Arthur</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">M</forename>
				<surname>Hunt</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">K</forename>
				<surname>Lee</surname>
			</persName>
		</author>
		<imprint>
			<date type="published" when="2006-02-09" />
			<pubPlace>Vancouver, B.C., Canadian Institute for Health Information</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="81,59.52,507.01,470.81,12.22;81,87.84,519.61,328.90,12.22" >
	<analytic>
		<title level="a" type="main">Managing PharmaCare: slow progress toward Cost-effective drug use and a sustainable program</title>
	</analytic>
	<monogr>
		<title level="j">Auditor General of British Columbia</title>
		<imprint>
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="81,59.52,544.32,473.05,12.22;81,87.84,556.92,284.52,12.22" >
	<analytic>
		<title level="a" type="main">Chapter 4: Management of Federal Drug Benefit Programs</title>
	</analytic>
	<monogr>
		<title level="j">Auditor General of Canada</title>
		<imprint>
			<date type="published" when="2004-11" />
		</imprint>
	</monogr>
	<note>Report. of the Auditor General to the House of Commons</note>
</biblStruct>

<biblStruct coords="81,59.52,581.64,456.08,12.22;81,87.84,594.24,241.68,12.22" >
	<analytic>
		<title level="a" type="main">Audit of the Drug Programs Activity of the Ministry of Health and Long-Term Care</title>
	</analytic>
	<monogr>
		<title level="j">Auditor General of Ontario</title>
		<imprint>
			<biblScope unit="page" from="189" to="221" />
			<date type="published" when="2001" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="81,59.52,618.84,335.02,12.22" >
	<analytic>
		<title level="a" type="main">Biotecanada orphan drug policy</title>
	</analytic>
	<monogr>
		<title level="j">BIOTECanada</title>
		<imprint>
			<biblScope unit="page">6</biblScope>
			<date type="published" when="2004" />
		</imprint>
	</monogr>
	<note>Policy. paper</note>
</biblStruct>

<biblStruct coords="81,59.52,643.56,463.92,12.22;81,87.84,656.16,8.28,12.22" >
	<analytic>
		<title level="a" type="main">Drug interchangeability update</title>
	</analytic>
	<monogr>
		<title level="m">British Columbia College of Pharmacists</title>
		<imprint>
			<date type="published" when="2004" />
			<biblScope unit="page">4</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="81,59.52,680.88,358.17,12.22" >
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="m">PharmaCare Trends</title>
		<meeting><address><addrLine>Victoria</addrLine></address></meeting>
		<imprint>
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="81,59.52,705.48,470.69,12.22;81,87.84,718.08,408.84,12.22;81,87.84,730.80,155.47,12.22" >
	<monogr>
		<title level="m" type="main">Application of Patient Safety Indicators in Manitoba: A First Look</title>
		<author>
			<persName>
				<forename type="first">S</forename>
				<surname>Bruce</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">H</forename>
				<surname>Prior</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">A</forename>
				<surname>Katz</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">M</forename>
				<surname>Taylor</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">S</forename>
				<surname>Latosinsky</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">P</forename>
				<surname>Martens</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">C</forename>
				<surname>De Coster</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">M</forename>
				<surname>Brownell</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">R</forename>
				<surname>Soodeen</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">C</forename>
				<surname>Steinbach</surname>
			</persName>
		</author>
		<imprint>
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="82,59.52,99.36,442.78,12.22;82,87.84,111.96,400.93,12.22;82,87.84,124.56,179.38,12.22" >
	<analytic>
		<title level="a" type="main">Topical corticosteroid prescribing patterns following changes in drug benefit status</title>
		<author>
			<persName>
				<forename type="first">C</forename>
				<surname>Campbell</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">C</forename>
				<surname>Cooke</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">S</forename>
				<surname>Weerasinghe</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">I</forename>
				<surname>Sketris</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">P</forename>
				<surname>Mclean-Veysey</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">C</forename>
				<surname>Skedgel</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Annals of Pharmacotherapy</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="787" to="793" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="82,59.52,149.28,407.28,12.22" >
	<analytic>
		<title level="a" type="main">Towards a Canadian orphan drug policy</title>
	</analytic>
	<monogr>
		<title level="j">Canadian Organization for Rare Disorders</title>
		<imprint>
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="82,59.52,173.88,437.40,12.22;82,87.84,186.60,34.63,12.22" >
	<analytic>
		<title level="a" type="main">Drug expenditure in Canada</title>
	</analytic>
	<monogr>
		<title level="j">Canadian Institute for Health Information – CIHI</title>
		<imprint>
			<date type="published" when="1985" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="82,59.52,211.20,437.40,12.22;82,87.84,223.92,34.63,12.22" >
	<analytic>
		<title level="a" type="main">Drug expenditure in Canada</title>
	</analytic>
	<monogr>
		<title level="j">Canadian Institute for Health Information – CIHI</title>
		<imprint>
			<date type="published" when="1985" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="82,59.52,248.52,458.29,12.22;82,87.84,261.12,430.41,12.22;82,87.84,273.84,24.84,12.22" >
	<analytic>
		<title level="a" type="main">Principles for providing information about prescription drugs to consumers &quot; , statement approved by the Canadian Medical Association Board of Directors</title>
	</analytic>
	<monogr>
		<title level="j">Canadian Medical Association</title>
		<imprint>
			<date type="published" when="2003-03" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="82,59.52,298.44,451.07,12.22;82,87.84,311.16,263.90,12.22" >
	<analytic>
		<title level="a" type="main">Direct-to-Consumer Advertising Policy Statement</title>
	</analytic>
	<monogr>
		<title level="j">Canadian Medical Association</title>
		<imprint>
			<date type="published" when="2002-09" />
		</imprint>
	</monogr>
	<note>statement. approved by the CMA Board of Directors</note>
</biblStruct>

<biblStruct coords="82,59.52,335.76,370.91,12.22" >
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Cancer Advocacy Coalition of Canada</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="26" to="38" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
	<note>Report. Card</note>
</biblStruct>

<biblStruct coords="82,59.52,360.37,471.93,12.22;82,87.84,373.09,415.52,12.22" >
	<monogr>
		<title level="m" type="main">Paying for what works: BC&apos;s experience with the Reference Drug Program as a model for rational policy making</title>
		<author>
			<persName>
				<forename type="first">A</forename>
				<surname>Cassels</surname>
			</persName>
		</author>
		<imprint>
			<date type="published" when="2002" />
			<pubPlace>Vancouver</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="82,59.52,397.69,464.74,12.22;82,87.84,410.41,152.98,12.22" >
	<analytic>
		<title level="a" type="main">Chapter 9: prescription drugs</title>
	</analytic>
	<monogr>
		<title level="m">Building on Values (Final report)</title>
		<imprint>
			<date type="published" when="2002" />
			<biblScope unit="page" from="189" to="210" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="82,59.52,435.01,432.08,12.22" >
	<monogr>
		<title level="m" type="main">Rapport annuel de gestion</title>
		<author>
			<persName>
				<surname>Conseil Du Medicament</surname>
			</persName>
		</author>
		<imprint>
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="82,59.52,459.61,432.08,12.22" >
	<monogr>
		<title level="m" type="main">Rapport annuel de gestion</title>
		<author>
			<persName>
				<surname>Conseil Du Medicament</surname>
			</persName>
		</author>
		<imprint>
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="82,59.52,484.33,454.36,12.22;82,87.84,496.93,415.76,12.22;82,87.84,509.65,187.32,12.22" >
	<analytic>
		<title level="a" type="main">Quantifying the use of the statin antilipemic drugs: comparisons and contrasts between Nova Scotia, Canada and Queensland, Australia</title>
		<author>
			<persName>
				<forename type="first">C</forename>
				<surname>Cooke</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">L</forename>
				<surname>Nissen</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">I</forename>
				<surname>Sketris</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">S</forename>
				<surname>Tett</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clinical Therapeutics</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="497" to="503" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="82,59.52,534.25,466.83,12.22;82,87.84,546.85,261.40,12.22" >
	<analytic>
		<title level="a" type="main">Prices and availability of pharmaceuticals: Evidence from nine countries</title>
		<author>
			<persName>
				<forename type="first">P</forename>
				<forename type="middle">M</forename>
				<surname>Danzon</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">M</forename>
				<forename type="middle">F</forename>
				<surname>Furukawa</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Health Affairs</title>
		<imprint>
			<biblScope unit="page" from="3" to="521" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
	<note>web. exclusive</note>
</biblStruct>

<biblStruct coords="82,59.52,571.57,453.07,12.22;82,87.84,584.17,430.23,12.22;82,87.84,596.89,165.36,12.22" >
	<monogr>
		<title level="m" type="main">Comparisons of retail prices of generic prescription drugs in Canada vs. United States: A comprehensive study</title>
		<author>
			<persName>
				<forename type="first">D</forename>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">Cruz</forename>
				<forename type="middle">J</forename>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">W</forename>
				<surname>Hejazi</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">G</forename>
				<surname>Fleischmann</surname>
			</persName>
		</author>
		<imprint>
			<date type="published" when="2005" />
		</imprint>
	</monogr>
	<note>A. Report Prepared for the Canadian Generic Pharmaceutical Association</note>
</biblStruct>

<biblStruct coords="82,59.52,621.49,466.03,12.22;82,87.84,634.09,198.48,12.22" >
	<analytic>
		<title level="a" type="main">The Pharmaceutical Industry in Figures, Key data – update</title>
	</analytic>
	<monogr>
		<title level="j">EFPIAEuropean Federation of Pharmaceutical Industries and Associations)</title>
		<imprint>
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="82,59.52,658.81,458.03,12.22;82,87.84,671.41,119.84,12.22" >
	<monogr>
		<title level="m" type="main">Drug expense coverage in the Canadian population: protection from severe drug expenses</title>
		<author>
			<persName>
				<forename type="first">Fraser</forename>
				<surname>Group</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">/</forename>
				<surname>Tristat Resources</surname>
			</persName>
		</author>
		<imprint>
			<date type="published" when="2002" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="82,59.52,696.13,447.68,12.22;82,87.84,708.73,439.27,12.22;82,87.84,721.45,19.32,12.22" >
	<analytic>
		<title level="a" type="main">Direct-to-consumer prescription drug advertising in Canada: Permission by Default?</title>
		<author>
			<persName>
				<forename type="first">D</forename>
				<forename type="middle">M</forename>
				<surname>Gardner</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">B</forename>
				<surname>Mintzes</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">A</forename>
				<surname>Ostry</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Canadian Medical Association Journal</title>
		<imprint>
			<biblScope unit="volume">169</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="425" to="427" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="83,59.52,99.36,427.03,12.22;83,87.84,111.96,212.18,12.22" >
	<analytic>
		<title level="a" type="main">Regulations amending the Food and Drug regulation (1390-data protection)</title>
		<author>
			<persName>
				<forename type="first">Canada</forename>
				<surname>Government</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Canada Gazette</title>
		<imprint>
			<biblScope unit="volume">138</biblScope>
			<biblScope unit="issue">50</biblScope>
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="83,59.52,136.56,456.50,12.22;83,87.84,149.28,216.36,12.22" >
	<analytic>
		<title level="a" type="main">Regulations amending the Patented Medicines (Notice of Compliance) Regulations</title>
		<author>
			<persName>
				<forename type="first">Canada</forename>
				<surname>Government</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Canada Gazette</title>
		<imprint>
			<biblScope unit="volume">138</biblScope>
			<biblScope unit="issue">50</biblScope>
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="83,59.52,173.88,119.27,12.22;83,178.80,172.48,5.28,7.70;83,186.72,173.88,61.64,12.22;83,248.40,172.48,4.69,7.70;83,255.84,173.88,258.11,12.22;83,87.84,186.60,416.14,12.22;83,87.84,199.20,329.16,12.22" >
	<monogr>
		<title level="m" type="main">39 th Parliament , 1 st Session Standing Committee on Health (HESA), Evidence from meeting on Prescription Drugs House of Commons Standing Committee on Heath</title>
		<author>
			<persName>
				<forename type="first">Canada</forename>
				<surname>Government</surname>
			</persName>
		</author>
		<imprint>
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="83,59.52,223.92,308.62,12.22;83,87.84,236.52,422.27,12.22;83,87.84,249.12,24.84,12.22" >
	<monogr>
		<title level="m" type="main">Canada&apos;s winning secrets summary</title>
		<author>
			<persName>
				<forename type="first">Canada</forename>
				<surname>Government</surname>
			</persName>
		</author>
		<imprint>
			<date type="published" when="2005-03" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="83,59.52,273.84,420.60,12.22" >
	<monogr>
		<title/>
		<author>
			<persName>
				<forename type="first">Ontario</forename>
				<surname>Government</surname>
			</persName>
		</author>
		<imprint>
			<date type="published" when="2004" />
		</imprint>
	</monogr>
	<note>Report. Card for the Ontario Drug Benefit Program</note>
</biblStruct>

<biblStruct coords="83,59.52,298.44,445.32,12.22;83,87.84,311.16,429.66,12.22;83,87.84,323.76,159.73,12.22" >
	<analytic>
		<title level="a" type="main">Inter-provincial variation in Government drug formularies</title>
		<author>
			<persName>
				<forename type="first">J</forename>
				<forename type="middle">P</forename>
				<surname>Grégoire</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">P</forename>
				<surname>Macneil</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">K</forename>
				<surname>Skilton</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">J</forename>
				<surname>Moisan</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">D</forename>
				<surname>Menon</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">P</forename>
				<surname>Jacobs</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">E</forename>
				<surname>Mckenzie</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">B</forename>
				<surname>Ferguson</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Canadian Journal of Public Health</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="307" to="312" />
			<date type="published" when="2001" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="83,59.52,348.36,472.54,12.22;83,87.84,361.08,428.98,12.22" >
	<analytic>
		<title level="a" type="main">Beneficiary Cost Sharing under Canadian Provincial Prescription Drug Benefit Programs: History and Assessment</title>
		<author>
			<persName>
				<forename type="first">P</forename>
				<surname>Grootendorst</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Canadian Journal of Clinical Pharmacology</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="79" to="99" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="83,59.52,385.68,440.91,12.22;83,87.84,398.40,434.22,12.22;83,87.84,411.00,367.20,12.22" >
	<analytic>
		<title level="a" type="main">The impact of reference pricing of cardiovascular drugs on health care costs and health outcomes: Evidence from British Columbia</title>
		<author>
			<persName>
				<forename type="first">P</forename>
				<surname>Grootendorst</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">L</forename>
				<surname>Dolovitch</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">A</forename>
				<forename type="middle">M</forename>
				<surname>Holbrook</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">A</forename>
				<forename type="middle">R</forename>
				<surname>Levy</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">B</forename>
				<forename type="middle">J</forename>
				<surname>O &apos;brien</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Report for the Canadian Health Services Research Foundation</title>
		<imprint>
			<date type="published" when="2001" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="83,59.52,435.60,471.59,12.22;83,87.84,448.32,404.84,12.22;83,87.84,460.92,302.38,12.22" >
	<analytic>
		<title level="a" type="main">The impact of reference pricing of nonsteroidal anti-inflammatory agents on the use and costs of analgesic drugs</title>
		<author>
			<persName>
				<forename type="first">P</forename>
				<surname>Grootendorst</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">J</forename>
				<forename type="middle">K</forename>
				<surname>Marshall</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">A</forename>
				<forename type="middle">M</forename>
				<surname>Holbrook</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">L</forename>
				<forename type="middle">R</forename>
				<surname>Dolovitch</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">B</forename>
				<forename type="middle">J</forename>
				<surname>O &apos;brien</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">A</forename>
				<forename type="middle">R</forename>
				<surname>Levy</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Health Services Research</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="1297" to="1317" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="83,59.52,485.64,471.86,12.22;83,87.84,498.24,381.38,12.22" >
	<analytic>
		<title level="a" type="main">A re-examination of the impact of reference pricing on anti-hypertensive drug plan expenditures in British Columbia</title>
		<author>
			<persName>
				<forename type="first">P</forename>
				<surname>Grootendorst</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">D</forename>
				<surname>Stewart</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Health Economics</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="735" to="742" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="83,59.52,522.84,430.25,12.22" >
	<analytic>
		<title level="a" type="main">Non-Insured Health Benefit Program – Annual report</title>
	</analytic>
	<monogr>
		<title level="j">Health Canada</title>
		<imprint>
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="83,59.52,547.56,448.65,12.22;83,87.84,560.16,187.86,12.22" >
	<analytic>
		<title level="a" type="main">Regulatory Review of Pharmaceuticals, Biologics and Medical Devices 2005 - Annual Summary of Performance</title>
	</analytic>
	<monogr>
		<title level="j">Health Canada</title>
		<imprint>
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="83,59.52,584.88,466.32,12.22;83,87.84,597.48,66.96,12.22" >
	<analytic>
		<title level="a" type="main">A National Formulary for Canada</title>
		<author>
			<persName>
				<forename type="first">A</forename>
				<surname>Hollis</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">S</forename>
				<surname>Law</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Canadian Public Policy</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="445" to="452" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="83,59.52,622.08,447.29,12.22;83,87.84,634.80,72.46,12.22;83,87.84,647.40,415.80,12.22;83,87.84,660.12,102.70,12.22" >
	<analytic>
		<title level="a" type="main">Prescription drug purchases by Canadian hospitals and pharmacies reach $16.57 billion in</title>
	</analytic>
	<monogr>
		<title level="j">IMS Health</title>
		<imprint>
			<date type="published" when="2005-03" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="83,59.52,684.72,257.64,12.22" >
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="m">IMS Drug Monitor: Canada</title>
		<imprint>
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="83,59.52,709.44,454.89,12.22;83,87.84,722.04,197.44,12.22" >
	<analytic>
		<title level="a" type="main">Prescription drug purchases by Canadian hospitals and pharmacies reach $16.57 billion in</title>
		<author>
			<persName>
				<forename type="first">Canada</forename>
				<surname>Ims Health</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">IMS Health</title>
		<imprint>
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="84,59.52,62.52,145.04,12.22" >
	<monogr>
		<title/>
		<author>
			<persName>
				<forename type="first">Delsa / Hea / Wd /</forename>
				<surname>Hwp</surname>
			</persName>
		</author>
		<imprint>
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="84,59.52,99.36,410.21,12.22" >
	<analytic>
		<title level="a" type="main">Canadian pharmaceutical industry profile</title>
	</analytic>
	<monogr>
		<title level="j">Industry Canada – Life Sciences Branch</title>
		<imprint>
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="84,59.52,123.96,438.84,12.22;84,87.84,136.56,398.98,12.22;84,87.84,149.28,162.00,12.22" >
	<analytic>
		<title level="a" type="main">Exhibit 1.19: Retail Prescriptions Filled at Pharmacies by State: Prescriptions Per Capita and Retail Prescription Sales</title>
		<author>
			<persName>
				<surname>Kaiser Family Foundation</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Trends and Indicators in the Changing Health Care Marketplace</title>
		<imprint>
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="84,59.52,173.88,463.17,12.22;84,87.84,186.60,430.62,12.22;84,87.84,199.20,323.32,12.22" >
	<analytic>
		<title level="a" type="main">Impact of criteria-based reimbursement policy on the use of respiratory drugs delivered by nebuliser and health care services utilisation in Nova Scotia, Canada</title>
		<author>
			<persName>
				<forename type="first">G</forename>
				<surname>Kephart</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">I</forename>
				<surname>Sketris</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">S</forename>
				<surname>Bowles</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">M</forename>
				<surname>Richard</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">C</forename>
				<surname>Cooke</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharmacotherapy</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1248" to="1257" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="84,59.52,223.92,441.65,12.22;84,87.84,236.52,255.77,12.22" >
	<analytic>
		<title level="a" type="main">Bill 102: An Act to amend the Drug Interchangeability and Dispensing Fee Act and the Ontaro Benefit Act</title>
	</analytic>
	<monogr>
		<title level="j">Legislative Assembly of Ontario</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="84,59.52,261.12,461.88,12.22;84,87.84,273.84,379.80,12.22" >
	<analytic>
		<title level="a" type="main">A comparison of new drug availability in Canada and the United States and potential therapeutic implications of differences</title>
		<author>
			<persName>
				<forename type="first">J</forename>
				<surname>Lexchin</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Health Policy</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="issue">2-3</biblScope>
			<biblScope unit="page" from="214" to="220" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="84,59.52,298.44,463.92,12.22;84,87.84,311.16,105.13,12.22" >
	<analytic>
		<title level="a" type="main">Out-of-pocket spending on prescription drugs</title>
		<author>
			<persName>
				<forename type="first">J</forename>
				<surname>Luffman</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Perspectives on Labour and Income</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="5" to="13" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="84,59.52,335.76,466.70,12.22;84,87.84,348.36,350.32,12.22" >
	<analytic>
		<title/>
		<author>
			<persName>
				<forename type="first">G</forename>
				<forename type="middle">P</forename>
				<surname>Marchildon</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Health Systems in Transition: Canada, Copenhagen, WHO, Regional Office for Europe on behalf of the European Observatory on Health Systems and Policies</title>
		<imprint>
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="84,59.52,373.08,472.34,12.22;84,87.84,385.68,33.84,12.22" >
	<monogr>
		<title level="m" type="main">Federal pharmacare: prescription for an ailing federation?</title>
		<author>
			<persName>
				<forename type="first">G</forename>
				<forename type="middle">P</forename>
				<surname>Marchildon</surname>
			</persName>
		</author>
		<imprint>
			<date type="published" when="2006" />
			<biblScope unit="page" from="94" to="108" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="84,59.52,410.40,454.73,12.22;84,91.77,423.00,415.57,12.22;84,87.84,435.60,441.12,12.22;84,87.84,448.32,80.64,12.22" >
	<analytic>
		<title level="a" type="main">Impact of reference-based pricing for histamine-2 receptor antagonists and restricted access to proton pump inhibitors in British Columbia</title>
		<author>
			<persName>
				<forename type="first">J</forename>
				<forename type="middle">K</forename>
				<surname>Marshall</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">P</forename>
				<forename type="middle">V</forename>
				<surname>Grootendorst</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">B</forename>
				<forename type="middle">J</forename>
				<surname>O &apos;brien</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">L</forename>
				<forename type="middle">R</forename>
				<surname>Dolovitch</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">A</forename>
				<forename type="middle">M</forename>
				<surname>Holbrook</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">A</forename>
				<forename type="middle">R</forename>
				<surname>Levy</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Canadian Medical Association Journal</title>
		<imprint>
			<biblScope unit="volume">166</biblScope>
			<biblScope unit="issue">13</biblScope>
			<biblScope unit="page" from="1655" to="1662" />
			<date type="published" when="2002" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="84,59.52,472.92,456.23,12.22;84,87.84,485.64,58.36,12.22" >
	<analytic>
		<title level="a" type="main">National pharmacare proposal</title>
		<author>
			<persName>
				<forename type="first">T</forename>
				<surname>Mcintosh</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Health Policy Monitor Bertelsmann Foundation, Survey</title>
		<imprint>
			<biblScope unit="issue">4</biblScope>
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="84,59.52,510.24,458.49,12.22;84,87.84,522.84,107.90,12.22" >
	<analytic>
		<title level="a" type="main">Tax Subsidies for R&amp;D in Canadian Provinces</title>
		<author>
			<persName>
				<forename type="first">K</forename>
				<forename type="middle">J</forename>
				<surname>Mckenzie</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Canadian Public Policy</title>
		<imprint>
			<biblScope unit="volume">XXXI</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="29" to="44" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="84,59.52,547.56,466.92,12.22;84,87.84,560.16,190.69,12.22" >
	<analytic>
		<title level="a" type="main">The common drug review: A NICE start for Canada?</title>
		<author>
			<persName>
				<forename type="first">M</forename>
				<surname>Mcmahon</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">S</forename>
				<surname>Morgan</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">C</forename>
				<surname>Mitton</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Health Policy</title>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="339" to="351" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="84,59.52,584.88,466.57,12.22;84,87.84,597.48,436.27,12.22;84,87.84,610.08,437.04,12.22;84,87.84,622.80,107.89,12.22" >
	<analytic>
		<title level="a" type="main">How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without DTCA</title>
		<author>
			<persName>
				<forename type="first">B</forename>
				<surname>Mintzes</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">M</forename>
				<forename type="middle">L</forename>
				<surname>Barer</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">R</forename>
				<forename type="middle">L</forename>
				<surname>Kravitz</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">K</forename>
				<surname>Bassett</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">J</forename>
				<surname>Lexchin</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">A</forename>
				<surname>Kazanjian</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">R</forename>
				<forename type="middle">G</forename>
				<surname>Evans</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">R</forename>
				<surname>Pan</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">S</forename>
				<forename type="middle">A</forename>
				<surname>Marion</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Canadian Medical Association Journal</title>
		<imprint>
			<biblScope unit="volume">169</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="405" to="412" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="84,59.52,647.40,450.29,12.22;84,87.84,660.12,224.77,12.22" >
	<analytic>
		<title level="a" type="main">Whither Seniors&apos; Pharmacare: Lessons from (and for) Canada</title>
		<author>
			<persName>
				<forename type="first">S</forename>
				<surname>Morgan</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">M</forename>
				<surname>Barer</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">J</forename>
				<forename type="middle">D</forename>
				<surname>Agnew</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Health Affairs</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="49" to="59" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="84,59.52,684.73,426.36,12.22;84,87.84,697.45,387.09,12.22" >
	<analytic>
		<title/>
		<author>
			<persName>
				<forename type="first">S</forename>
				<surname>Morgan</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">A</forename>
				<surname>Kozyrskyj</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">C</forename>
				<surname>Metge</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">N</forename>
				<surname>Roos</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">M</forename>
				<surname>Dahl</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Pharmaceuticals: Therapeutic Interchange and Pricing Policies</title>
		<imprint>
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="84,59.52,722.05,458.79,12.22;84,87.84,734.65,55.92,12.22" >
	<analytic>
		<title level="a" type="main">Drug spending in Canada: recent trends and causes</title>
		<author>
			<persName>
				<forename type="first">S</forename>
				<surname>Morgan</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Medical Care</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="635" to="642" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="85,59.52,99.36,458.16,12.22;85,87.84,111.96,159.73,12.22" >
	<analytic>
		<title level="a" type="main">Outcome-based drug coverage in British Columbia</title>
		<author>
			<persName>
				<forename type="first">S</forename>
				<surname>Morgan</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">K</forename>
				<surname>Basset</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">B</forename>
				<surname>Mintzes</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Health Affairs</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="269" to="276" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="85,59.52,136.56,449.30,12.22;85,87.84,149.28,266.20,12.22" >
	<monogr>
		<title level="m" type="main">The Canadian Rx Atlas, The Centre for Health Services and Policy Research</title>
		<author>
			<persName>
				<forename type="first">S</forename>
				<surname>Morgan</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">M</forename>
				<surname>Mcmahon</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">J</forename>
				<surname>Lam</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">D</forename>
				<surname>Mooney</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">C</forename>
				<surname>Raymond</surname>
			</persName>
		</author>
		<imprint>
			<date type="published" when="2005" />
			<pubPlace>Vancouver</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="85,59.52,173.88,444.24,12.22;85,87.84,186.60,56.65,12.22" >
	<analytic>
		<title level="a" type="main">Ministère de la santé et des services sociaux)</title>
	</analytic>
	<monogr>
		<title level="m">Politique du médicament</title>
		<imprint>
			<date type="published" when="2004" />
		</imprint>
	</monogr>
	<note>Document. de consultation</note>
</biblStruct>

<biblStruct coords="85,59.52,211.20,471.18,12.22;85,87.84,223.92,391.03,12.22;85,87.84,236.52,179.38,12.22" >
	<analytic>
		<title level="a" type="main">Pharmacists&apos; participation in an inhaled respiratory medication program: Reimbursement of professional fees</title>
		<author>
			<persName>
				<forename type="first">A</forename>
				<surname>Murphy</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">N</forename>
				<surname>Mackinnon</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">P</forename>
				<surname>Flanagan</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">S</forename>
				<surname>Bowles</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">I</forename>
				<surname>Sketris</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annals of Pharmacotherapy</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="655" to="661" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="85,59.52,261.12,459.95,12.22;85,87.84,273.84,428.66,12.22;85,87.84,286.44,111.57,12.22" >
	<analytic>
		<title level="a" type="main">National Institute for Health Care Management Foundation The National Institute for Health Care Management Research and Educational Foundation</title>
	</analytic>
	<monogr>
		<title level="m">Prescription Drugs and Mass Media Advertising</title>
		<meeting><address><addrLine>Washington</addrLine></address></meeting>
		<imprint>
			<date type="published" when="2000" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="85,59.52,311.16,398.72,12.22" >
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="m">OECD Health Data 2005: Statistics and Indicators for 30 Countries</title>
		<meeting><address><addrLine>Paris</addrLine></address></meeting>
		<imprint>
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="85,59.52,335.76,248.51,12.22" >
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="m">OECD Economic Survey: Canada</title>
		<meeting><address><addrLine>Paris</addrLine></address></meeting>
		<imprint>
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="85,59.52,360.37,440.13,12.22;85,87.84,373.09,76.44,12.22" >
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Ontario Ministry of Health and Long Term Care</title>
		<imprint>
			<date type="published" when="2004" />
		</imprint>
	</monogr>
	<note>Report. Card for the Ontario Drug Benefit Program</note>
</biblStruct>

<biblStruct coords="85,59.52,397.69,396.60,12.22" >
	<analytic>
		<title/>
		<author>
			<persName>
				<surname>Palmer D &apos;angelo Consulting Inc</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Generic drug prices: A Canada US comparison</title>
		<imprint>
			<date type="published" when="2002" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="85,59.52,422.41,460.84,12.22;85,87.84,435.01,241.70,12.22" >
	<analytic>
		<title level="a" type="main">Status of legislation on pharmaceutical reimportation: The relevance of IP laws to reimportation</title>
		<author>
			<persName>
				<forename type="first">B</forename>
				<forename type="middle">F</forename>
				<surname>Palumbo</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Managed Care</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="3" to="6" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="85,59.52,459.61,463.22,12.22;85,87.84,472.33,72.24,12.22" >
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="m">Competitiveness and performance indicators</title>
		<imprint>
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="85,59.52,496.93,443.99,12.22;85,87.84,509.65,421.00,12.22;85,87.84,522.25,131.37,12.22" >
	<analytic>
		<title level="a" type="main">Provincial drug plans overview reports – Pharmaceutical Trends</title>
	</analytic>
	<monogr>
		<title level="j">PMPRBPatented Medicine Prices Review Board)</title>
		<imprint>
			<biblScope unit="volume">9600</biblScope>
			<date type="published" when="1995" />
		</imprint>
	</monogr>
	<note>Report. prepared by PMPRB for the F/P/T Working group on drug prices</note>
</biblStruct>

<biblStruct coords="85,59.52,546.85,470.19,12.22;85,87.84,559.57,420.55,12.22;85,87.84,572.17,34.63,12.22" >
	<analytic>
		<title level="a" type="main">A study of the prices of the Top selling multiple source medicines in Canada, prepared by PMPRB for the F</title>
	</analytic>
	<monogr>
		<title level="j">PMPRBPatented Medicine Prices Review Board)</title>
		<imprint>
			<date type="published" when="2002" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="85,59.52,596.89,457.20,12.22;85,87.84,609.49,34.63,12.22" >
	<analytic>
		<title level="a" type="main">Verification of foreign patented drug prices</title>
	</analytic>
	<monogr>
		<title level="j">PMPRB (Patented Medicine Prices Review Board)</title>
		<imprint>
			<date type="published" when="2002" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="85,59.52,634.09,465.12,12.22;85,87.84,646.81,34.63,12.22" >
	<analytic>
		<title level="a" type="main">Foreign Price trends for patented medicines</title>
	</analytic>
	<monogr>
		<title level="j">PMPRB (Patented Medicine Prices Review Board)</title>
		<imprint>
			<date type="published" when="2002" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="85,59.52,671.41,467.22,12.22;85,87.84,684.13,291.90,12.22" >
	<analytic>
		<title level="a" type="main">A comparison of pharmaceutical Research &amp; Development Spending in Canada and selected countries</title>
	</analytic>
	<monogr>
		<title level="j">PMPRB (Patented Medicine Prices Review Board)</title>
		<imprint>
			<date type="published" when="2002" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="85,59.52,708.73,456.83,12.22;85,87.84,721.45,433.94,12.22;85,87.84,734.05,103.01,12.22" >
	<analytic>
		<title level="a" type="main">Top selling non-patented single source drug products: international comparison</title>
	</analytic>
	<monogr>
		<title level="j">PMPRBPatented Medicine Prices Review Board)</title>
		<imprint>
			<date type="published" when="1998" />
		</imprint>
	</monogr>
	<note>prepared. by PMPRB for the F/P/T Working group on drug prices</note>
</biblStruct>

<biblStruct coords="86,59.52,99.36,440.13,12.22;86,87.84,111.96,89.70,12.22" >
	<analytic>
		<title level="a" type="main">Compendium of Guidelines, Policies and procedures</title>
	</analytic>
	<monogr>
		<title level="j">PMPRB (Patented Medicine Prices Review Board)</title>
		<imprint>
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="86,59.52,136.56,396.35,12.22" >
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">PMPRB (Patented Medicine Prices Review Board) Annual Report</title>
		<imprint>
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="86,59.52,161.28,451.54,12.22;86,87.84,173.88,89.10,12.22" >
	<analytic>
		<title level="a" type="main">Budget impact analysis guidelines: Needs assessment</title>
	</analytic>
	<monogr>
		<title level="j">PMPRB (Patented Medicine Prices Review Board)</title>
		<imprint>
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="86,59.52,198.60,471.44,12.22;86,87.84,211.20,126.21,12.22" >
	<analytic>
		<title level="a" type="main">The impact upon public drug plans of changes in drug distribution</title>
	</analytic>
	<monogr>
		<title level="j">PMPRB (Patented Medicine Prices Review Board)</title>
		<imprint>
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="86,59.52,235.92,396.35,12.22" >
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">PMPRB (Patented Medicine Prices Review Board) Annual Report</title>
		<imprint>
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="86,59.52,260.52,454.38,12.22;86,87.84,273.12,142.12,12.22" >
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">PMPRB (Patented Medicine Prices Review Board) Analytical Study Series</title>
		<imprint>
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="86,59.52,297.84,436.62,12.22;86,87.84,310.44,250.32,12.22" >
	<analytic>
		<title level="a" type="main">Non-patented prescription drug prices reporting – Canadian and Foreign Price trends</title>
	</analytic>
	<monogr>
		<title level="j">PMPRB (Patented Medicine Prices Review Board)</title>
		<imprint>
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="86,59.52,335.16,466.24,12.22;86,87.84,347.76,192.62,12.22" >
	<analytic>
		<title level="a" type="main">Discussion guide for the consultations on the Board&apos;s excessive price guidelines</title>
	</analytic>
	<monogr>
		<title level="j">PMPRB (Patented Medicine Prices Review Board)</title>
		<imprint>
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="86,59.52,372.36,448.17,12.22;86,87.84,385.08,430.45,12.22;86,87.84,397.68,140.04,12.22" >
	<monogr>
		<title level="m" type="main">What effects do provincial drug plan policies for new drugs have on patterns of use and cost?</title>
		<author>
			<persName>
				<forename type="first">M</forename>
				<surname>Paterson</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">K</forename>
				<surname>Bassett</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">M</forename>
				<surname>Mamdani</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">J</forename>
				<surname>Wright</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">G</forename>
				<surname>Naglie</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">A</forename>
				<surname>Laupacis</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">G</forename>
				<surname>Anderson</surname>
			</persName>
		</author>
		<imprint>
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="86,59.52,422.40,405.78,12.22;86,87.84,435.00,358.32,12.22" >
	<analytic>
		<title level="a" type="main">Ontario&apos;s formulary committee: How recommendations are made?</title>
		<author>
			<persName>
				<forename type="first">A</forename>
				<forename type="middle">M</forename>
				<surname>Pausjenssen</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">P</forename>
				<forename type="middle">A</forename>
				<surname>Singer</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">A</forename>
				<forename type="middle">S</forename>
				<surname>Detsky</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharmacoeconomics</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="285" to="294" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="86,59.52,459.60,297.60,12.22" >
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="m">PAAB Review</title>
		<imprint>
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="86,59.52,484.32,422.62,12.22" >
	<monogr>
		<title level="m" type="main">Drugs makers expected to shun Canada The Globe and Mail</title>
		<author>
			<persName>
				<forename type="first">L</forename>
				<surname>Priest</surname>
			</persName>
		</author>
		<imprint>
			<date type="published" when="2006-06-23" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="86,59.52,508.92,469.66,12.22;86,87.84,521.64,86.88,12.22" >
	<analytic>
		<title level="a" type="main">Generic Pharmaceuticals and Sector Development -Industry Challenges and Potential Solutions</title>
	</analytic>
	<monogr>
		<title level="j">Public Policy Forum</title>
		<imprint>
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="86,59.52,546.24,427.79,12.22;86,92.36,558.84,438.73,12.22;86,87.84,571.56,193.24,12.22" >
	<analytic>
		<title level="a" type="main">Outcome of reference pricing for angiotensin-converting enzyme inhibitors</title>
		<author>
			<persName>
				<forename type="first">S</forename>
				<surname>Schneeweiss</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">A</forename>
				<forename type="middle">M</forename>
				<surname>Walker</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">R</forename>
				<forename type="middle">J</forename>
				<surname>Glynn</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">M</forename>
				<surname>Maclure</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">C</forename>
				<surname>Dormuth</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">S</forename>
				<forename type="middle">B</forename>
				<surname>Soumerai</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">New England Journal of Medicine</title>
		<imprint>
			<biblScope unit="volume">346</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="822" to="829" />
			<date type="published" when="2002" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="86,59.52,596.16,466.65,12.22;86,87.84,608.88,408.72,12.22;86,87.84,621.48,308.68,12.22" >
	<analytic>
		<title level="a" type="main">Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization</title>
		<author>
			<persName>
				<forename type="first">S</forename>
				<surname>Schneeweiss</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">S</forename>
				<forename type="middle">B</forename>
				<surname>Soumerai</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">R</forename>
				<forename type="middle">J</forename>
				<surname>Glynn</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">M</forename>
				<surname>Maclure</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">C</forename>
				<surname>Dormuth</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">A</forename>
				<forename type="middle">M</forename>
				<surname>Walker</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Canadian Medical Association Journal</title>
		<imprint>
			<biblScope unit="volume">166</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="737" to="745" />
			<date type="published" when="2002" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="86,59.52,646.08,465.51,12.22;86,87.84,658.80,425.64,12.22;86,87.84,671.40,274.30,12.22" >
	<analytic>
		<title level="a" type="main">Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers</title>
		<author>
			<persName>
				<forename type="first">S</forename>
				<surname>Schneeweiss</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">S</forename>
				<forename type="middle">B</forename>
				<surname>Soumerai</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">M</forename>
				<surname>Maclure</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">C</forename>
				<surname>Dormuth</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">A</forename>
				<forename type="middle">M</forename>
				<surname>Walker</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">R</forename>
				<forename type="middle">J</forename>
				<surname>Glynn</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clinical Pharmacology &amp; Therapeutics</title>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="page" from="388" to="400" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="86,59.52,696.12,456.28,12.22;86,87.84,708.72,413.65,12.22;86,87.84,721.44,283.47,12.22" >
	<analytic>
		<title level="a" type="main">Net health plan savings from reference pricing for angiotensin-converting enzyme inhibitors in elderly British Columbia residents</title>
		<author>
			<persName>
				<forename type="first">S</forename>
				<surname>Schneeweiss</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">C</forename>
				<surname>Dormuth</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">P</forename>
				<surname>Grootendorst</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">S</forename>
				<forename type="middle">B</forename>
				<surname>Soumerai</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">M</forename>
				<surname>Maclure</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Medical Care</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="653" to="660" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="87,59.52,99.36,455.61,12.22;87,87.84,111.96,436.12,12.22;87,87.84,124.56,179.89,12.22" >
	<analytic>
		<title level="a" type="main">Taking the pulse of health care systems: experiences of patients with health problems in six countries</title>
		<author>
			<persName>
				<forename type="first">C</forename>
				<surname>Schoen</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">R</forename>
				<surname>Osborn</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">P</forename>
				<forename type="middle">Trang</forename>
				<surname>Huynh</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">M</forename>
				<surname>Doty</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">K</forename>
				<surname>Zapert</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">J</forename>
				<surname>Peugh</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">K</forename>
				<surname>Davis</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Health Affairs</title>
		<imprint>
			<biblScope unit="page" from="5" to="509" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
	<note>Web. -exclusive</note>
</biblStruct>

<biblStruct coords="87,59.52,149.28,462.59,12.22;87,87.84,161.88,391.11,12.22;87,87.84,174.60,314.28,12.22" >
	<analytic>
		<title level="a" type="main">The use of the World Health Organisation Anatomical Therapeutic Chemical/ Defined daily dose methodology in Canada</title>
		<author>
			<persName>
				<forename type="first">I</forename>
				<surname>Sketris</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">C</forename>
				<surname>Metge</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">J</forename>
				<surname>Ross</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">M</forename>
				<surname>Maccara</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">D</forename>
				<surname>Comeau</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">G</forename>
				<surname>Kephart</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">J</forename>
				<surname>Blackburn</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">J</forename>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Drug Information Journal</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="1" to="13" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="87,59.52,199.20,458.96,12.22;87,87.84,211.92,443.68,12.22;87,87.84,224.52,438.12,12.22;87,87.84,237.12,284.76,12.22" >
	<analytic>
		<title level="a" type="main">Comparison of anti-infective drug use in elderly persons in Manitoba, Nova Scotia, and Saskatchewan, Canada: Relationship to drug insurance reimbursement policies</title>
		<author>
			<persName>
				<forename type="first">I</forename>
				<surname>Sketris</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">C</forename>
				<surname>Metge</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">Y</forename>
				<surname>Schevchuk</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">D</forename>
				<surname>Comeau</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">G</forename>
				<surname>Kephart</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">J</forename>
				<surname>Blackburn</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">M</forename>
				<surname>Maccara</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">A</forename>
				<surname>Laturnas</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The American Journal of Geriatric Pharmacotherapy</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="24" to="35" />
			<date type="published" when="2004-03" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="87,59.52,261.84,411.87,12.22;87,87.84,274.44,435.47,12.22;87,87.84,287.16,275.76,12.22" >
	<analytic>
		<title level="a" type="main">The effects of deinsuring chlorpropamide on the prescribing of oral antihyperglycemics for Nova Scotia Seniors Pharmacare beneficiaries</title>
		<author>
			<persName>
				<forename type="first">I</forename>
				<surname>Sketris</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">G</forename>
				<surname>Kephart</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">D</forename>
				<surname>Frail</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">C</forename>
				<surname>Skedgel</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">M</forename>
				<surname>Allen</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharmacotherapy</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="784" to="791" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="87,59.52,311.76,453.58,12.22;87,87.84,324.36,437.85,12.22;87,87.84,337.08,102.37,12.22" >
	<analytic>
		<title level="a" type="main">Use of Physician Profiles to influence prescribing of topical corticosteroids</title>
		<author>
			<persName>
				<forename type="first">I</forename>
				<surname>Sketris</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">G</forename>
				<surname>Kephart</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">C</forename>
				<surname>Cooke</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">C</forename>
				<surname>Skedgel</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">P</forename>
				<surname>Mclean-Veysey</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Canadian Journal of Clinical Pharmacology</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="186" to="197" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="87,59.52,361.68,452.60,12.22;87,87.84,374.40,311.31,12.22" >
	<monogr>
		<title level="m" type="main">Generic Drugopoly: Why Non-patented Prescription Drugs Cost More in Canada than in the United States and Europe. The Fraser Institute</title>
		<author>
			<persName>
				<forename type="first">B</forename>
				<forename type="middle">J</forename>
				<surname>Skinner</surname>
			</persName>
		</author>
		<imprint>
			<date type="published" when="2004" />
			<pubPlace>Vancouver</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="87,59.52,399.00,446.02,12.22;87,87.84,411.60,426.07,12.22;87,87.84,424.32,51.09,12.22" >
	<monogr>
		<title level="m" type="main">Canada&apos;s Drug Price Paradox: The Unexpected Losses Caused by Government Interference in Pharmaceutical Markets. Fraser Institute digital publication, The Fraser Institute</title>
		<author>
			<persName>
				<forename type="first">B</forename>
				<forename type="middle">J</forename>
				<surname>Skinner</surname>
			</persName>
		</author>
		<imprint>
			<date type="published" when="2005" />
			<pubPlace>Vancouver</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="87,59.52,448.92,462.61,12.22;87,87.84,461.65,419.32,12.22;87,87.84,474.25,51.09,12.22" >
	<analytic>
		<title level="a" type="main">Price Controls, Patents, and Cross-Border Internet Pharmacies: Risks to Canada&apos;s Drug Supply and International Trading Relations The Fraser Institute</title>
		<author>
			<persName>
				<forename type="first">B</forename>
				<forename type="middle">J</forename>
				<surname>Skinner</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Critical Issues Bulletin</title>
		<imprint>
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="87,59.52,498.85,470.02,12.22;87,87.84,511.57,191.76,12.22;87,87.84,524.17,410.28,12.22;87,87.84,536.88,89.02,12.22" >
	<analytic>
		<title level="a" type="main">Science and Technology, The Health of Canadians – The Federal Role, Final Report</title>
	</analytic>
	<monogr>
		<title level="m">Standing Senate Committee on Social Affairs</title>
		<imprint>
			<date type="published" when="2002-03" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="87,59.52,561.48,432.07,12.22;87,87.84,574.08,437.85,12.22;87,87.84,586.80,56.03,12.22" >
	<monogr>
		<title level="m" type="main">Patent protection for pharmaceutical products, Government of Canada, Law and Government Division</title>
		<author>
			<persName>
				<forename type="first">M</forename>
				<surname>Smith</surname>
			</persName>
		</author>
		<imprint>
			<date type="published" when="1993-03" />
		</imprint>
	</monogr>
	<note>bp354. -e.htm, accessed 1</note>
</biblStruct>

<biblStruct coords="87,59.52,611.40,460.17,12.22;87,87.84,624.12,271.60,12.22" >
	<analytic>
		<title level="a" type="main">Estimates of total spending on research and development in the health field in Canada</title>
	</analytic>
	<monogr>
		<title level="j">Statistics Canada Sciences Statistics, Service Bulletin</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">3</biblScope>
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="87,59.52,648.72,435.10,12.22;87,87.84,661.44,434.02,12.22;87,87.84,674.04,427.92,12.22;87,87.84,686.64,105.14,12.22" >
	<analytic>
		<title level="a" type="main">Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons</title>
		<author>
			<persName>
				<forename type="first">R</forename>
				<surname>Tamblyn</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">R</forename>
				<surname>Laprise</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">J</forename>
				<forename type="middle">A</forename>
				<surname>Hanley</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">M</forename>
				<surname>Abrahamowicz</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">S</forename>
				<surname>Scott</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">N</forename>
				<surname>Mayo</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">J</forename>
				<surname>Hurley</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">R</forename>
				<surname>Grad</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">E</forename>
				<surname>Latimer</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">R</forename>
				<surname>Perreault</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">P</forename>
				<surname>Mcleod</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">A</forename>
				<surname>Huang</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">P</forename>
				<surname>Larochelle</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">L</forename>
				<surname>Mallet</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">285</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="421" to="429" />
			<date type="published" when="2001" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="87,59.52,711.36,352.44,12.22" >
	<monogr>
		<title level="m" type="main">A national formulary for Canada</title>
		<imprint>
			<date type="published" when="2004" />
		</imprint>
	</monogr>
	<note>working. paper</note>
</biblStruct>

<biblStruct coords="88,59.52,62.52,145.04,12.22" >
	<monogr>
		<title/>
		<author>
			<persName>
				<forename type="first">Delsa / Hea / Wd /</forename>
				<surname>Hwp</surname>
			</persName>
		</author>
		<imprint>
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="88,59.52,99.36,464.13,12.22;88,87.84,111.96,110.62,12.22;88,59.52,136.56,445.83,12.22;88,87.84,149.28,285.96,12.22" >
	<analytic>
		<title level="a" type="main">NAFTA 10 Years Later, International Trade Administration, Office of Industry Trade Policy, Health policy versus industrial policy in the pharmaceutical sector: the case of Canada</title>
		<author>
			<persName>
				<forename type="first">M</forename>
				<surname>Vandergrift</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">P</forename>
				<surname>Kanavos</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Health Policy</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="241" to="260" />
			<date type="published" when="1997" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="88,59.52,173.88,435.36,12.22;88,87.84,186.60,270.79,12.22" >
	<analytic>
		<title level="a" type="main">L&apos;industrie pharmaceutique dans l&apos;Union Européenne</title>
		<author>
			<persName>
				<forename type="first">G</forename>
				<surname>Vekeman</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Statistiques en bref, Industrie, commerce et services</title>
		<imprint>
			<date type="published" when="2005" />
		</imprint>
	</monogr>
	<note>Communautés. Européennes</note>
</biblStruct>

<biblStruct coords="88,59.52,211.20,454.44,12.22;88,87.84,223.92,220.27,12.22" >
	<analytic>
		<title level="a" type="main">The Relevance of Intellectual Property Laws to Reimportation</title>
		<author>
			<persName>
				<forename type="first">W</forename>
				<forename type="middle">J</forename>
				<surname>Wagner</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Managed Care, supplement</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="20" to="22" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="88,71.82,248.52,412.26,12.22;88,87.84,261.12,443.55,12.22;88,87.84,273.84,85.89,12.22" >
	<analytic>
		<title level="a" type="main">Financial incentives and prescribing</title>
	</analytic>
	<monogr>
		<title level="m">Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity and Quality</title>
		<editor>Mossialos, M. Mrazek and T. Walley</editor>
		<meeting><address><addrLine>Maidenhead</addrLine></address></meeting>
		<imprint>
			<publisher>Open University Press</publisher>
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="88,59.52,298.45,427.95,12.22;88,87.84,311.17,238.52,12.22" >
	<analytic>
		<title level="a" type="main">Economic and Policy Implications of Reimportation: A Canadian Perspective</title>
		<author>
			<persName>
				<forename type="first">C</forename>
				<surname>Ward</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Managed Care</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="17" to="20" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="88,59.52,335.77,455.41,12.22;88,87.84,348.37,74.89,12.22" >
	<analytic>
		<title level="a" type="main">Quality improvement will require a major commitment</title>
		<author>
			<persName>
				<forename type="first">R</forename>
				<surname>Wilson</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hospital Quarterly</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="20" to="24" />
			<date type="published" when="2001" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="89,385.08,62.52,145.04,12.22" >
	<monogr>
		<title/>
		<author>
			<persName>
				<forename type="first">Delsa / Hea / Wd /</forename>
				<surname>Hwp</surname>
			</persName>
		</author>
		<imprint>
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="89,290.76,767.04,11.04,12.22;89,202.80,124.20,186.77,12.22;89,59.52,139.58,351.85,9.96;89,59.52,166.32,473.37,12.22;89,103.56,178.92,178.82,12.22;89,59.52,194.64,473.47,12.22;89,103.56,207.24,429.63,12.22;89,103.56,219.96,134.27,12.22;89,59.52,235.56,473.41,12.22;89,103.56,248.16,24.54,12.22;89,59.52,263.88,473.45,12.22;89,103.56,276.48,429.53,12.22;89,103.56,289.20,398.60,12.22;89,59.52,304.80,473.39,12.22;89,103.56,317.40,128.75,12.22;89,59.52,333.12,473.53,12.22;89,103.56,345.72,136.44,12.22;89,59.52,361.44,473.57,12.22;89,103.56,374.04,272.79,12.22;89,59.52,389.64,473.46,12.22;89,103.56,402.36,291.92,12.22;89,59.52,417.96,473.48,12.22;89,103.56,430.68,387.18,12.22;89,59.52,446.28,473.49,12.22;89,103.56,459.00,429.64,12.22;89,103.56,471.60,71.25,12.22;89,59.52,487.20,473.49,12.22;89,103.56,499.92,368.20,12.22;89,59.52,515.52,473.46,12.22;89,103.56,528.24,47.79,12.22;89,59.52,543.84,473.56,12.22;89,103.56,556.44,422.59,12.22;89,59.52,572.16,473.55,12.22;89,103.56,584.76,59.63,12.22;89,59.52,600.48,24.50,12.22;89,102.00,600.48,431.08,12.22;89,103.56,613.08,122.04,12.22;89,59.52,628.68,24.50,12.22;89,102.00,628.68,430.81,12.22;89,103.56,641.40,78.36,12.22;89,59.52,657.00,24.50,12.22;89,102.00,657.00,431.05,12.22;89,103.56,669.72,237.94,12.22;89,59.52,685.32,24.50,12.22;89,102.00,685.32,430.98,12.22;89,103.56,697.92,348.51,12.22" >
	<analytic>
		<title level="a" type="main">Maria Luisa Gil Lapetra and the HCQI Expert Group Members No. 21 Nicole Tapay and Francesca Colombo No. 17 SKILL-MIX AND POLICY CHANGE IN THE HEALTH WORKFORCE Eddy van Doorslaer, Cristina Masseria and the OECD Health Equity Research Group No. 13 DEMENTIA CARE IN 9 OECD COUNTRIES: A COMPARATIVE</title>
		<author>
			<persName>
				<forename type="first">Oecd</forename>
				<surname>Health</surname>
			</persName>
		</author>
		<author>
			<persName>
				<surname>Papers</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">Health</forename>
				<surname>Papers</surname>
			</persName>
		</author>
		<author>
			<persName>
				<surname>Care</surname>
			</persName>
		</author>
		<author>
			<persName>
				<surname>Indicators</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">Conceptual</forename>
				<surname>Project</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">Edward</forename>
				<surname>Framework Paper Soeren Mattke</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">Peter</forename>
				<surname>Kelley</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">Jeremy</forename>
				<forename type="middle">Hurst</forename>
				<surname>Scherer</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">Steven</forename>
				<surname>Simeons</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">Jeremy</forename>
				<surname>Hurst No</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">Consumer</forename>
				<surname>20</surname>
			</persName>
		</author>
		<author>
			<persName>
				<surname>Direction</surname>
			</persName>
		</author>
		<author>
			<persName>
				<surname>Choice</surname>
			</persName>
		</author>
		<author>
			<persName>
				<surname>Long-Term</surname>
			</persName>
		</author>
		<author>
			<persName>
				<surname>Care</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">Including</forename>
				<surname>Older Persons</surname>
			</persName>
		</author>
		<author>
			<persName>
				<surname>Payments</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">Mike</forename>
				<surname>Informal Care Steven Simoens</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">Jeremy</forename>
				<surname>Villeneuve</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">Private</forename>
				<surname>Hurst</surname>
			</persName>
		</author>
		<author>
			<persName>
				<surname>Health</surname>
			</persName>
		</author>
		<author>
			<persName>
				<surname>In</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="middle">A</forename>
				<surname>Netherlands</surname>
			</persName>
		</author>
		<author>
			<persName>
				<surname>Case</surname>
			</persName>
		</author>
		<author>
			<persName>
				<surname>Study</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">this series can be found on the OECD website: www.oecd HOW CAN IT HELP IMPROVE CARE OUTCOMES, EMPLOYMENT AND FISCAL SUSTAINABILITY? (2005) Jens Lundsgaard No. 19 TACKLING NURSE SHORTAGES IN OECD COUNTRIES Colombo and Nicole Tapay No. 14 INCOME-RELATED INEQUALITY IN THE USE OF MEDICAL CARE IN 21 OECD COUNTRIES Myung-Yong Um and the Dementia Experts&apos; Group No. 12 PRIVATE HEALTH INSURANCE IN FRANCE (2004) Thomas C. Buchmueller and Agnes Couffinhal No. 11 THE SLOVAK HEALTH INSURANCE SYSTEM AND THE POTENTIAL ROLE FOR PRIVATE HEALTH INSURANCE: POLICY CHALLENGES (2004) Francesca Colombo and Nicole Tapay No. 10 PRIVATE HEALTH INSURANCE IN IRELAND. A CASE STUDY (2004) Francesca Colombo and Nicole Tapay No. 9 HEALTH CARE SYSTEMS: LESSONS FROM THE REFORM EXPERIENCE (2003) Elizabeth Docteur and Howard Oxley No. 8 PRIVATE HEALTH INSURANCE IN AUSTRALIA. A CASE STUDY (2003) Francesca Colombo and Nicole Tapay No. 7 EXPLAINING WAITING-TIMES VARIATIONS FOR ELECTIVE SURGERY ACROSS OECD COUNTRIES (2003) Luigi Siciliani and Jeremy Hurst No. 6 TACKLING EXCESSIVE WAITING TIMES FOR ELECTIVE SURGERY: A COMPARISON OF POLICIES IN 12 OECD COUNTRIES</title>
		<editor>Eva Orosz and David Morgan</editor>
		<imprint>
			<publisher>Pierre Moise Jeremy Hurst and Luigi Siciliani</publisher>
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

			</listBibl>
		</back>
	</text>
</TEI>
